Secord, A. A., Pothuri, B., Backes, F., Thaker, P., Gehrig, P., Previs, R., … Bae-Jump, V. (2022). Genomic alterations, molecularly targeted therapy and race: Real world data from the Endometrial Cancer Molecularly Targeted Therapy Consortium. In GYNECOLOGIC ONCOLOGY (Vol. 166, pp. S52–S53).

Secord, Angeles Alvarez, Bhavana Pothuri, Floor Backes, Premal Thaker, Paola Gehrig, Rebecca Previs, Lindsay Borden, et al. “Genomic alterations, molecularly targeted therapy and race: Real world data from the Endometrial Cancer Molecularly Targeted Therapy Consortium.” In GYNECOLOGIC ONCOLOGY, 166:S52–53, 2022.

Secord AA, Pothuri B, Backes F, Thaker P, Gehrig P, Previs R, et al. Genomic alterations, molecularly targeted therapy and race: Real world data from the Endometrial Cancer Molecularly Targeted Therapy Consortium. In: GYNECOLOGIC ONCOLOGY. 2022. p. S52–3.

Secord, Angeles Alvarez, et al. “Genomic alterations, molecularly targeted therapy and race: Real world data from the Endometrial Cancer Molecularly Targeted Therapy Consortium.” GYNECOLOGIC ONCOLOGY, vol. 166, 2022, pp. S52–53.

Secord AA, Pothuri B, Backes F, Thaker P, Gehrig P, Previs R, Borden L, Thomas S, Biostatistics M, Jackson A, Konecny G, Duska L, Arend R, Wright J, Corr B, Maxwell GL, Cosgrove C, Mullen M, Moore K, Herzog T, Cohen J, Gockley A, Gaillard S, Fader A, Berchuck A, Bae-Jump V. Genomic alterations, molecularly targeted therapy and race: Real world data from the Endometrial Cancer Molecularly Targeted Therapy Consortium. GYNECOLOGIC ONCOLOGY. 2022. p. S52–S53.